COVID-19 boosters are still strongly recommended for aging adults, particularly those aged 65 and older, because they remain at higher risk for severe illness, hospitalization, and death from COVID-19 due to the natural weakening of the immune system that comes with age. Updated booster vaccines are designed to target the most current circulating variants of the virus, helping to maintain and enhance protection in this vulnerable group.
As of 2025, new COVID-19 vaccine formulations have been approved specifically for older adults. These vaccines are tailored to combat the latest dominant strains, such as the LP.8.1 variant, which is prevalent in communities. The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) continue to recommend that adults 65 and older receive these updated boosters to reduce their risk of severe outcomes from COVID-19. This recommendation also extends to individuals with underlying health conditions that increase their vulnerability, such as heart disease, diabetes, or cancer.
The rationale behind continuing booster shots for older adults lies in the fact that immunity from previous vaccinations or infections tends to wane over time, and the virus itself evolves. Boosters help to “remind” the immune system and improve its ability to recognize and fight off newer variants. This is especially important for aging adults because their immune responses are generally less robust compared to younger people.
In practical terms, the 2025-2026 COVID-19 vaccines are available and being distributed widely through pharmacies, clinics, and healthcare providers. Older adults are encouraged to consult their doctors about eligibility and timing for receiving the booster. Importantly, these updated vaccines can be administered alongside the seasonal flu shot, which is also recommended for older adults to protect against influenza, another serious respiratory illness that can cause complications in this age group.
Despite some recent changes in vaccine distribution policies and eligibility criteria for younger populations, the guidance for older adults remains clear and consistent: getting the updated COVID-19 booster is a key part of staying protected during the respiratory virus season. This approach helps reduce hospitalizations and deaths, easing the burden on healthcare systems and improving quality of life for seniors.
In some regions, emergency measures have been enacted to ensure that older adults can access the updated vaccines easily, even overriding federal restrictions that might limit vaccine availability. This underscores the public health priority placed on protecting aging populations from COVID-19.
Overall, the ongoing recommendation for COVID-19 boosters in aging adults reflects a balance of evolving scientific evidence
